Skip to content

Author

Zeynep Irmak Kaya

We have 3 of 13 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Association of Sodium-Glucose Cotransporter-2 Inhibitor Use with Laboratory- and Anthropometry-Derived Indices of Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Retrospective Cohort Study

Abstract Sodium-glucose cotransporter-2 inhibitors lower body weight, and their association with liver steatosis and fibrosis scores in routine practice is uncertain. We performed a retrospective cohort study of 493 adults with type 2 diabetes of at least 5 years’ duration at a tertiary hospital in Türkiye. Of these, 2...

H. Hamarat, Özge Alkan Tali, Zeynep Irmak Kaya et al. · 0 citations
Open access Sep 2026

Integrated Risk Stratification Using Comorbidity Burden, Frailty, and Systemic Inflammation to Predict 30-Day Mortality in Older Emergency Department Patients: A Prospective Cohort Study

Although CCI was the strongest individual predictor, the integrated model achieved the highest observed discrimination and its incremental benefit over some two-predictor models was modest and not statistically significant.

Kâmil Konur, Nurullah Parça, Bünyamin Onur Harmancı et al. · 1 citation
Open access Aug 2026

THE RELATIONSHIP BETWEEN THE TRIGLYCERIDE-GLUCOSE INDEX AND INSULIN RESISTANCE, INFLAMMATION, IRON METABOLISM AND MICRONUTRIENT PROFILE IN INDIVIDUALS WITH OBESITY

Introduction: The aim of this study was to compare metabolic parameters, inflammatory markers, indicators of iron metabolism and micronutrient levels among groups of obese individuals categorised according to the Triglyceride-Glucose (TyG) index, and to assess the relationship between the TyG index and these parameters...

Zeynep Irmak Kaya, Abdulkadir Sağdıç, H. H. Çoban et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.